This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garcia, L. S.
Right arrow Articles by Chan, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garcia, L. S.
Right arrow Articles by Chan, F.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2003, p. 209-212, Vol. 41, No. 1
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.1.209-212.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Commercial Assay for Detection of Giardia lamblia and Cryptosporidium parvum Antigens in Human Fecal Specimens by Rapid Solid-Phase Qualitative Immunochromatography

Lynne S. Garcia,1* Robyn Y. Shimizu,2 Susan Novak,3 Marilyn Carroll,4 and Frank Chan5

LSG & Associates, Santa Monica, California 90402,1 Department of Pathology and Laboratory Medicine, University of California, Los Angeles, California 90095,2 Microbiology, Kaiser Permanente, North Hollywood, California 91605,3 Turner Laboratory, Torrance, California 90745,4 Microbiology, Children's Hospital of Eastern Ontario, Ottawa, Ontario K1H 8L1, Canada5

Received 27 June 2002/ Returned for modification 6 August 2002/ Accepted 2 September 2002

The ImmunoCard STAT! Cryptosporidium/Giardia rapid assay (Meridian Bioscience, Inc.) is a solid-phase qualitative immunochromatographic assay that detects and distinguishes between Giardia lamblia and Cryptosporidium parvum in aqueous extracts of human fecal specimens (fresh, frozen, unfixed, or fixed in 5 or 10% formalin or sodium acetate-acetic acid-formalin). By using specific antibodies, antigens specific for these organisms are isolated and immobilized on a substrate. After the addition of appropriate reagents, a positive test is detected visually by the presence of a gray-black color bar (regardless of the intensity) next to the organism name printed on the test device. A control is included in the device. Steps include tube preparation (buffer, patient specimen, conjugates A and B), testing (addition of sample onto the test device), and visual reading (total time, 12 min). Test performance was evaluated with known positive and negative stool specimens (170 specimens positive for Giardia and 231 specimens negative for Giardia) (85 specimens positive for Cryptosporidium and 316 specimens negative for Cryptosporidium); they were tested with trichrome, iron-hematoxylin, or modified acid-fast stains or the Meridian Bioscience, Inc., Giardia/Cryptosporidium Merifluor combination reagent; specimens with discrepant results were retested by using the Merifluor combination reagent. On the basis of the results of the reference methods, the sensitivities, specificities, and positive and negative predictive values were as follows: for G. lamblia, 93.5, 100, 100, and 95.5%, respectively; for C. parvum, 98.8, 100, 100, and 99.7%, respectively. False-negative results for G. lamblia were obtained with specimens with low parasite numbers (n = 7) or specimens containing trophozoites only (n = 3); one specimen with a false-negative result contained numerous cysts. The one specimen false negative for C. parvum was confirmed to be positive by immunofluorescence. No cross-reactivity was seen with 10 different protozoa (152 challenges), nine different helminths (35 challenges), or human cells (4 challenges) found in fecal specimens. This rapid test system may be very beneficial in the absence of trained microscopists; however, for patients who remain symptomatic after a negative result, the ova and parasite examination and special stains for other coccidia and the microsporidia should always remain options.


* Corresponding author. Mailing address: LSG & Associates, 512 12th St., Santa Monica, CA 90402-2908. Phone: (310) 393-5059. Fax: (310) 899-9722. E-mail: Lynnegarcia2{at}earthlink.net.


Journal of Clinical Microbiology, January 2003, p. 209-212, Vol. 41, No. 1
0095-1137/03/$08.00+0     DOI: 10.1128/JCM.41.1.209-212.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Youn, S., Kabir, M., Haque, R., Petri, W. A. Jr. (2009). Evaluation of a Screening Test for Detection of Giardia and Cryptosporidium Parasites. J. Clin. Microbiol. 47: 451-452 [Abstract] [Full Text]  
  • Leo, M., Haque, R., Kabir, M., Roy, S., Lahlou, R. M., Mondal, D., Tannich, E., Petri, W. A. Jr. (2006). Evaluation of Entamoeba histolytica Antigen and Antibody Point-of-Care Tests for the Rapid Diagnosis of Amebiasis. J. Clin. Microbiol. 44: 4569-4571 [Abstract] [Full Text]  
  • Garcia, L. S., Garcia, J. P. (2006). Detection of Giardia lamblia Antigens in Human Fecal Specimens by a Solid-Phase Qualitative Immunochromatographic Assay. J. Clin. Microbiol. 44: 4587-4588 [Abstract] [Full Text]  
  • Robertson, L. J., Forberg, T., Hermansen, L., Gjerde, B. K., Alvsvag, J. O., Langeland, N. (2006). Cryptosporidium parvum Infections in Bergen, Norway, during an Extensive Outbreak of Waterborne Giardiasis in Autumn and Winter 2004.. Appl. Environ. Microbiol. 72: 2218-2220 [Abstract] [Full Text]  
  • Guy, R. A., Xiao, C., Horgen, P. A. (2004). Real-Time PCR Assay for Detection and Genotype Differentiation of Giardia lamblia in Stool Specimens. J. Clin. Microbiol. 42: 3317-3320 [Abstract] [Full Text]  
  • Chisholm, S. A., Watson, C. L., Teare, E. L., Saverymuttu, S., Owen, R. J. (2004). Non-invasive diagnosis of Helicobacter pylori infection in adult dyspeptic patients by stool antigen detection: does the rapid immunochromatography test provide a reliable alternative to conventional ELISA kits?. J Med Microbiol 53: 623-627 [Abstract] [Full Text]